Electrophysiological Effects of Carvedilol Administration in Patients with Dilated Cardiomyopathy

被引:0
|
作者
Emmanuel M. Kanoupakis
Emmanuel G. Manios
Hercules E. Mavrakis
Eleftherios M. Kallergis
George M. Lyrarakis
Emmanuel P. Koutalas
Panos E. Vardas
机构
[1] Heraklion University Hospital,Cardiology Department
来源
关键词
carvedilol; dilated cardiomyopathy; refractoriness; arrhythmias;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:169 / 176
页数:7
相关论文
共 50 条
  • [1] Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy
    Kanoupakis, Emmanuel M.
    Manios, Emmanuel G.
    Mavrakis, Hercules E.
    Kallergis, Eleftherios M.
    Lyrarakis, George M.
    Koutalas, Emmanuel P.
    Vardas, Panos E.
    CARDIOVASCULAR DRUGS AND THERAPY, 2008, 22 (03) : 169 - 176
  • [2] Effects of long-term carvedilol administration in patients with idiopathic dilated cardiomyopathy
    Metra, M
    Nodari, S
    Raccagni, D
    Garbellini, M
    Boldi, E
    Grigolato, M
    Rosselli, F
    Zanini, R
    Cas, LD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 17146 - 17146
  • [3] Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy. A prospective, double-blind, placebo-controlled study
    Kanoupakis, E. M.
    Manios, E. G.
    Mavrakis, H. E.
    Kallergis, E. M.
    Lyrarakis, G. M.
    Vardas, P. E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 401 - 401
  • [4] BENEFICIAL EFFECTS OF CARVEDILOL IN DILATED CARDIOMYOPATHY IN DIALYSIS PATIENTS
    Sharma, Alok
    Herzog, Charles
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E887 - E887
  • [5] Complex ventricular arrhythmias in patients with dilated cardiomyopathy: Effects of carvedilol
    Cice, G
    Ferrara, L
    Tagliamonte, E
    Turturo, M
    D'isa, S
    Natale, F
    di Uccio, FS
    Iacono, A
    CARDIOVASCULAR PHARMACOTHERAPY, 2000, : 361 - 364
  • [6] Electrophysiological effects of levosimendan administration in patients with advanced heart failure secondary to ischemic or dilated cardiomyopathy
    Kanoupakis, E. M.
    Kallergis, E. M.
    Mavrakis, H. E.
    Lyrarakis, G. M.
    Koutalas, E. P.
    Goudis, C.
    Manios, E. G.
    Vardas, P. E.
    EUROPEAN HEART JOURNAL, 2008, 29 : 301 - 301
  • [7] Electrophysiological effects of levosimendan administration in patients with advanced heart failure secondary to ischemic or dilated cardiomyopathy
    Mavrakis, H. E.
    Kanoupakis, E. M.
    Kallergis, E. M.
    Koutalas, E. P.
    Lathourakis, C. E.
    Nyktari, E. G.
    Manios, E. G.
    Vardas, P. E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 44 - 45
  • [8] Carvedilol therapy in pediatric patients with dilated cardiomyopathy
    Askari, Huelya
    Semizel, Evren
    Bostan, Oezlem M.
    Cil, Erguen
    TURKISH JOURNAL OF PEDIATRICS, 2009, 51 (01) : 22 - 27
  • [9] Carvedilol in dogs with dilated cardiomyopathy
    Oyama, Mark A.
    Sisson, D. David
    Prosek, Robert
    Bulmer, Barret J.
    Luethy, Mike W.
    Fuentes, Virginia Luis
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2007, 21 (06) : 1272 - 1279
  • [10] Carvedilol in infants with dilated cardiomyopathy
    Butnariu, A.
    Andreica, M.
    Munteanu, C.
    Oprita, S.
    Danciut, I.
    ACTA PAEDIATRICA, 2007, 96 : 118 - 119